Ji Z. Cao - Publications

Multi-omics integration analysis of the amino-acid metabolism-related genes identifies putatively causal variants of ACCS associated with hepatitis B virus-related hepatocellular carcinoma survival.

Journal: BMC cancer

Published: August 31, 2024

Genetic Variants of UGP2 and FBP2 in the Glycolysis Pathway Independently Predict Survival of Patients with HBV-Related Hepatocellular Carcinoma.

Journal: Journal of hepatocellular carcinoma

Published: August 21, 2024

Novel genetic variants in the NLRP3 inflammasome-related PANX1 and APP genes predict survival of patients with hepatitis B virus-related hepatocellular carcinoma.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: May 15, 2024

Genetic Variants in p53 Pathway Genes Affect Survival of Patients with HBV-Related Hepatocellular Carcinoma.

Journal: Journal of hepatocellular carcinoma

Published: January 16, 2024

Associations between modifiable risk factors and hepatocellular carcinoma: a trans-ancestry Mendelian randomization study.

Journal: BMC cancer

Published: November 29, 2023

Functional genetic variants of the disulfidptosis-related INF2 gene predict survival of hepatitis B virus-related hepatocellular carcinoma.

Journal: Carcinogenesis

Published: November 27, 2023

Association between novel genetic variants of Notch signaling pathway genes and survival of hepatitis B virus-related hepatocellular carcinoma.

Journal: Cancer medicine

Published: September 16, 2023

Associations between genetic variants in sphingolipid metabolism pathway genes and hepatitis B virus-related hepatocellular carcinoma survival.

Journal: Frontiers in oncology

Published: July 31, 2023

Potentially Functional Genetic Variants in the NRF2 Signaling Pathway Genes are Associated With HBV-related Hepatocellular Carcinoma Survival.

Journal: Journal of Cancer

Published: July 27, 2023

Fatty acid binding protein 5 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by degradation of Krüppel-like factor 9 mediated by miR-889-5p via cAMP-response element binding protein.

Journal: Cancer biology & therapy

Published: July 11, 2022

A miR-182 variant and risk of hepatocellular carcinoma in a southern Chinese population.

Journal: Human genomics

Published: April 28, 2020

Epigallocatechin gallate induces chemopreventive effects on rats with diethylnitrosamine‑induced liver cancer via inhibition of cell division cycle 25A.

Journal: Molecular medicine reports

Published: March 11, 2020